IBt and Russian state fund RUSNANO set up joint 23M EUR venture to manufacture prostate cancer implants in Russia
Berlin, 09 April 2009. International Brachytherapy S.A. (IBt), an associated
company of Eckert & Ziegler AG (ISIN DE0005659700), together with the
Russian state fund Rusnanotech and local partners, will set up a joint
venture to supply Russian prostate cancer patients with therapeutic implants
and other innovative medical devices. A declaration of the establishment of
"NanoBrachyTech", in which IBt will hold a minority share, was signed
yesterday in Berlin.
The joint venture, which will be based in Moscow, wants to invest up to EUR
23.2 million in the next five years on acquiring manufacturing licenses,
building a production facility and expanding the distribution network. The
special systems for producing the weakly radioactive implants are to be
obtained from Pankow-based Eckert & Ziegler BEBIG GmbH, a world leader in
the field of automation technology for radioactive components.
"The fact that the people in charge in Russia have chosen IBt as their
comprehensive partner and supplier for their modernization work in the
healthcare sector provides proof of the Group's competence and the
international recognition that the treatment of prostate cancer with weakly
radioactive implants has now attained," said Andreas Eckert, chairman of the
board of Eckert & Ziegler and supervisory board chairman of IBt. "For IBT,
in addition, the joint venture demonstrates that interesting growth
prospects for innovative radiation technology exist not only within the
European core markets but also in markets which were previously
underdeveloped, such as Russia."
The Eckert & Ziegler Group, which is predicting turnover of around EUR 100
million for 2009 and has approximately 520 employees, is one of the world's
largest suppliers of isotope technology components for radiation therapy and
nuclear medicine.
The Board of Directors
Your contact person should you have any queries:
Eckert & Ziegler AG, Karolin Riehle, Public Relations
Robert-Rössle-Str. 10, D-13125 Berlin, Tel.: +49 (0) 30 / 941084-138,
Fax-112
E-mail: karolin.riehle@ezag.de, www.ezag.de
